One exception to FDA’s new policy of reducing requirements to disseminate Medication Guides is if there is a material change to the MedGuide, such as a new indication or new safety information, according to the agency’s final guidance.
“Medication Guides – Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)” explains how FDA will use discretion...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?